NDC 86032-057 - Terbinafine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86032-057
- Package NDCs from labels
- 86032-057-01
- Manufacturer
- Evereen Shanghai Biotechnology Ltd. | Yumen Qianhua Pharmaceutical Co., Ltd.
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Terbinafine Hydrochloride | Evereen Shanghai Biotechnology Ltd. | Yumen Qianhua Pharmaceutical Co., Ltd. | 2025-08-21 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86032-057-01 | Terbinafine Hydrochloride | 1000 g in 1 BAG | POWDER | 1000 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terbinafine | TERBINAFINE HYDROCHLORIDE | Proficient Rx LP | 50657431-1cd9-42dd-9cfc-57db8713d267 | 2024-04-01 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Bryant Ranch Prepack | e2ecf7a5-1c84-4977-8a87-d1bfb9658668 | 2024-02-07 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Breckenridge Pharmaceutical, Inc. | c3832113-f517-4b4e-bf9c-31fce1a638e1 | 2023-12-22 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | A-S Medication Solutions | ef8370dc-8ca4-411d-87e1-dc6af3191330 | 2023-12-09 | Warnings | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | A-S Medication Solutions | 6605103b-fd71-4438-8496-f48973b98901 | 2023-10-31 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Proficient Rx LP | 4e515f99-7fc7-4692-9105-8e87c27d4e79 | 2022-08-01 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Proficient Rx LP | 76f7525d-2005-4da8-a795-50ede6236c68 | 2022-07-01 | Warnings | 012C11ZU6G |
| TERBINAFINE HYDROCHLORIDE | TERBINAFINE TABLETS 250 MG | Cipla USA Inc. | daf41866-6f2b-4483-b575-456becd6e85f | 2021-01-05 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine | TERBINAFINE | Exelan Pharmaceuticals Inc. | 6dc279cc-9861-4fa8-8083-ca3b3c57b513 | 2020-10-29 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine | TERBINAFINE | Proficient Rx LP | 3925dc10-ad66-46a8-bfa5-1a4314be3521 | 2020-01-01 | Warnings, Adverse reactions | 012C11ZU6G |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 808dab18-43f1-4895-a023-edbde722863e | 2017-12-15 | Warnings, Adverse reactions | 012C11ZU6G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.